Methyl 4-phenylbutanoate, 95.0%, 10g

1-(2-Hydroxyethyl)piperazine>99.0%(GC)25g

2-Chloro-1-{1-[(4-fluorophenyl)methyl]-2,5-dimethyl-1h-pyrrol-3-yl}ethan-1-one, 98%, 100mg

3,6,6-Trimethyl-4-oxo-4,5,6,7-tetrahydro-benzofuran-2-carboxylic acid, 95.0%, 250mg

(R)-2-amino-3-(2,3-difluorophenyl)propanoic acid, 98%, 500mg

(R)-2-Fluoro-5-methyl-N-(4-(4-(morpholin-2-ylmethoxy)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)benzenesulfonamide hydrochloride, 10mg

BENZO[D]THIAZOLE-4-CARBOXYLIC ACID, 95.0%, 10g

GC capillary column ROTI®Cap-1, 60 m, 0.32 mm, 0.35 µm, 1 Piece(s)

2-(Diethylcarbamoyl)-3,6-difluorobenzoic acid, 98%, 1g

3,5-Dimethyl-2-methoxyacetophenone, 5g

4-Chloro-1,10-phenanthroline, 97%, 100mg

(R)-1,1-Dimethoxypropan-2-ol, 98%, 1g

N-(2-Hydroxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 98%, 250mg